Biomedical Catalyst Accelerator Provider Pool EoI: early stage

Innovate UK, part of UK Research and Innovation (UKRI), is seeking expressions of interest to establish an approved provider pool to support delivery of the Biomedical Catalyst Accelerator Programme. This competition aims to identify experienced providers with a proven track record of designing and delivering end to end accelerator programmes for innovative UK registered, micro, small and medium sized enterprises (SMEs) aligned to Biomedical Catalyst or wider health and life sciences accelerator themes. Providers may be called upon over a period of up to three years to support programme delivery, subject to specific themes and requirements. The early stage accelerator strand requires applicants to demonstrate experience of delivering programmes supporting early stage innovative human health SMEs; including ideation, business model development, customer discovery and early commercial validation. Support must be tailored to the needs of SMEs working across a wide range of biomedical and healthcare R&D themes. Future accelerators are expected to support 10-15 participants per programme with total costs up to £500,000. Applicants must be from a single organisation (consortia are not permitted) and must demonstrate a proven track record of designing and delivering structured accelerator programmes for innovative SMEs. Applications must clearly set out how providers will deliver structured, high quality accelerator programmes to innovative SMEs when called upon, including approach to programme design and delivery, quality assurance, and monitoring and evaluation of outcomes. While there is no immediate funding in this expression of interest competition, total eligible project costs for any future funding will be 100% funded. Selected providers will join an approved provider pool and may be invited to deliver programmes over a three-year period.